| Overview |
| bs-21401R-APC-Cy5.5 |
| VLDL Receptor Polyclonal Antibody, APC-Cy5.5 Conjugated |
| WB |
| Human, Mouse, Rat, Dog, Pig, Rabbit, Horse |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human VLDL Receptor |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7436 |
| P98155 |
| Cytomembrane |
| Very low density lipoprotein receptor; VLDL R; VLDLR; VLDL-R; VLDLRCH. |
| Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity). |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz